President's Message
For almost 150 years, the presidents of the ANA have been thought leaders of academic neurology and neuroscience, with their fingers on the pulse of issues affecting the profession. Read the latest from today’s ANA president, M. Elizabeth Ross, MD, PhD, FANA, as well as the perspectives of past ANA presidents.
Dr. Ross is the Nathan E. Cumming Professor of Neurology and Neuroscience Chair, Neuroscience Graduate Program, Director, Center for Neurogenetics at Weill Cornell Medicine Feil Family Brain & Mind Research Institute. Her research focuses on how genes direct he construction of cellular organization and connectivity of brain.
– Dear colleagues,
– First, I would like to send heartfelt congratulations to Chair Andy Josephson, and the entire UCSF Neurology department, on achieving the well-deserved #1 spot in the recent USNWR ratings of Neurology and Neurosurgery departments.
– As COVID hospitalization rates moderate, at least in some parts of the country, many of our institutions have relaxed their restrictions on in-person meetings, and even on mask requirements.
– With the recent news that Biogen’s Aduhelm™ medication for Alzheimer's disease would be priced at $56,000 annually, I started thinking about how we go into the situation where market competition is allowed to control medication pricing in this country.
– The term “microaggression” was coined by psychiatrist and Harvard University professor Chester M. Pierce in 1970 to describe insults and dismissals which he regularly witnessed non-black Americans inflicting on African Americans.
– Happy Passover and Easter to all ANA members.
– First, on behalf of the ANA, let me extend our thoughts and best wishes to our members in Texas who have had their lives disrupted by the latest winter storm.